Increased dosage of DYRK1A leads to congenital heart defects in a mouse model of Down syndrome.
Ontology highlight
ABSTRACT: Down syndrome (DS) is caused by trisomy of human chromosome 21 (Hsa21). DS is a gene dosage disorder that results in multiple phenotypes including congenital heart defects. This clinically important cardiac pathology is the result of a third copy of one or more of the approximately 230 genes on Hsa21, but the identity of the causative dosage-sensitive genes and hence mechanisms underlying this cardiac pathology remain unclear. Here, we show that hearts from human fetuses with DS and embryonic hearts from the Dp1Tyb mouse model of DS show reduced expression of mitochondrial respiration genes and cell proliferation genes. Using systematic genetic mapping, we determined that three copies of the dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1a) gene, encoding a seri
SUBMITTER: Lana-Elola E
PROVIDER: S-EPMC7615651 | biostudies-literature | 2024 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA